Centro Integral de Medicina Respiratoria (CIMER) - Tucumán

Somos un centro de investigaciones clínicas con más de 30 años de experiencia, buscando una mejor calidad de vida para nuestros pacientes.
Centro Integral de Medicina Respiratoria (CIMER) - Tucumán
Combate de San Lorenzo 1241, T4000CBC San Miguel de Tucumán, Tucumán, Argentina
Select an option

Specializations

Neumonología
Reumatología
Nefrología
Neumonología pediátrica
Cardiología
Diagnostico por imágenes (Adultos y niños)

Patients Benefits

Oportunidades de nuevos tratamientos en enfermedades con necesidades insatisfechas
Acceso a especialistas certificados con amplia trayectoria
Un espacio comodo y de fácil acceso

Our team

Authorities
Director médico, subinvestigador, especialista en diagnostico por imágenesGonzalo Hernán Altieri Mohedano
Gerencia-Tecnica espirometríaMaria Veronica Altieri Mohedano
Director médico, investigador principal, neumonólogoHector Hugo Altieri
Director médico, investigador principal, reumatólogoRodolfo Sebastián Perez Alamino
Medical staff
Investigador principal, nefrólogoSantiago Alonso
Subinvestigador-Neumonólogo pediatraSantiago Assaf
Subinvestigadora, neumonólogaMaria Veronica Rojas
Subinvestigadora, reumatólogaPriscila Maria Marcaida
Legal and Administrative staff
SecretariaMagdalena Fernandez

Open studies

Asthma
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma - INC 54707-208 - Incyte CorporationSee more
A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma - AmgenSee more
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations - FLAIR - Teva Branded Pharmaceutical Products R&D, Inc.See more
Chronic obstructive pulmonary disease
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease - THARROS - AstraZenecaSee more
Lupus
Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) - SIRIUS-SLE 2 - Novartis PharmaceuticalsSee more
Pulmonary fibrosis
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) - TETON-PPF - United TherapeuticsSee more
Vasculitis
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA) - OCEAN - GlaxoSmithKlineSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy